What Researchers Did
Researchers conducted a systematic review of 38 studies — covering both animal and human research — to examine the mechanisms, effectiveness, and safety of hyperbaric oxygen and normobaric (regular pressure) oxygen therapies for intracranial hemorrhage (bleeding in the brain).
What They Found
HBO works by reducing cerebral vasospasm, promoting new blood vessel growth, suppressing inflammation, and improving energy metabolism in the brain. Normobaric oxygen mainly protects the blood-brain barrier and reduces brain swelling. Clinical trials showed improved neurological function recovery and lower mortality in some patients. However, excessive oxygen can have harmful effects, making dose selection critical.
What This Means for Canadian Patients
For Canadians who survive a brain bleed, oxygen therapy — particularly HBO — shows real promise for improving neurological recovery and survival. The key challenge is optimizing the dose, since too much oxygen can be harmful. This is an area where a specialist referral to a hyperbaric program may be valuable for select patients.
Canadian Relevance
No direct Canadian connection identified. Intracranial hemorrhage is not a standard OHIP-covered indication for HBOT in Ontario.
Study Limitations
The review includes only 8 clinical studies of oxygen therapy in ICH patients, and the remaining 30 were mechanistic or safety studies — the direct evidence in humans remains limited.